Charlie Harper
Contact information
Research groups
Colleges
Charlie Harper
BSc, MSc
Medical Statistician
Charlie is an Epidemiologist within the Wearables Group at the Big Data Institute and Nuffield Department of Population Health. His current research interests include the use of wearables data in risk prediction modelling and digital trial endpoints.
He joined the department in 2015 as a Medical Statistician and has contributed to numerous studies including large-scale randomised trials, meta-analyses, and observational studies in both cardiovascular and kidney disease. Charlie obtained his DPhil in Population Health from the Nuffield Department of Population Health, where he investigated whether routinely collected healthcare data can be used to reliably follow-up participants in large randomised trials. He completed his undergraduate degree in Economics at the University of East Anglia and MSc in Economics at Bristol University.
Recent publications
-
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.
Journal article
Sydes MR. et al, (2024), Contemp Clin Trials
-
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2024), Lancet Child Adolesc Health
-
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2023), Lancet Diabetes Endocrinol, 11, 905 - 914
-
Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data.
Journal article
Harper C. et al, (2023), Heart
-
Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)
Journal article
HERRINGTON W. et al, (2023), Kidney International Reports